Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-27 @ 11:26 PM
Study NCT ID:
NCT04503694
Status:
RECRUITING
Last Update Posted:
2025-03-05
First Post:
2020-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Sponsor:
Jules Bordet Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-28
First Submit QC Date:
None
Study First Post Date:
2020-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-05
Last Update Post Date Type:
ACTUAL